Inaktiver Wert

Onyx Pharmaceuticals, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Onyx Pharmaceuticals : Amgen Receives CHMP Positive Opinions for Two New Treatment Options for Patients with Blood Cancer in Europe	01.10.15
Onyx Pharmaceuticals : Amgen Submits Supplemental New Drug Application for Kyprolis® (Carflizomib) in Relapsed Multiple Myeloma	23.07.15
Onyx Pharmaceuticals : Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (Carflizomib) in Patients with Relapsed and Refractory Multiple Myeloma	31.05.15
Onyx Pharmaceuticals : Amgen to Advance Understanding of the Treatment of Blood Cancers at the 20th Congress of European Hematology Association (EHA)	27.05.15
Onyx Pharmaceuticals : Amgen Data at ASCO 2015 Highlight Oncology Pipeline and Portfolio	13.05.15

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103 Mrd.
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28 Mrd.
ARGENX SE	+1.69%	22.15 Mrd.
BIONTECH SE	-17.37%	21.02 Mrd.
GENMAB A/S	-9.30%	18.15 Mrd.
WUXI APPTEC CO., LTD.	-41.01%	16.74 Mrd.
BEIGENE, LTD.	-14.85%	16.05 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68 Mrd.
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17 Mrd.